BioPharm International-01-01-2019

BioPharm International

Internal and External Challenges to Biopharma in 2019

January 01, 2019

From the Editor

32

1

Pricing pressures, investment volatility, and government disfunction greet Biopharma in 2019.

CDER Priorities for 2019: Opioids, Quality, Safety, and Innovation

January 01, 2019

Regulatory Beat

32

1

FDA plans to support initiatives to ensure that all medicines are safe, effective, and of high quality.

Global Inspection Harmonization

January 01, 2019

Ask the Expert

32

1

Understanding the differences in inspection processes is the key to successful global expansion, according to Siegfried Schmitt, PhD, vice-president Technical, PAREXEL Consulting.

BioPharm International, January 2019 Issue (PDF)

January 01, 2019

Issue PDF

32

1

Click the title above to open the BioPharm International January 2019 issue in an interactive PDF format.